Canberra

A Randomized, Double-Masked, 48-Week, Parallel-Group, Placebo-Controlled, Proof-Of-Concept Study To Investigate The Efficacy And Safety Of Rg7774 In Patients With Diabetes Mellitus Type 1 Or Type 2 With Treatment-Naïve Diabetic Retinopathy.

Study Type  : Interventional  (Clinical Trial)
Estimated Enrollment  : 135 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Double (Participant, Investigator)
Primary Purpose: Treatment
Official Title: A Randomized, Double-Masked, 48-Week, Parallel-Group, Placebo-Controlled, Proof-of-Concept Study to Investigate the Efficacy and Safety of RG7774 in Patients With Diabetes Mellitus Type 1 or Type 2 With Treatment-Naive Diabetic Retinopathy
Actual Study Start Date  : June 5, 2020
Estimated Primary Completion Date  : June 1, 2023
Estimated Study Completion Date  : June 1, 2023

Related Publications

Our Affiliates